Literature DB >> 8679517

Models of glycerol-induced acute renal failure in rats.

Y Zurovsky1.   

Abstract

Acute renal failure (ARF) following rhabdomyolysis is not uncommon in man. The popular model for ARF formation following rhabdomyolysis in experimental animals is glycerol injection into the leg muscle following a 24 hour period of water deprivation. A large percentage of patients developing ARF following rhabdomyolysis do not suffer from such long periods of water deprivation. On the contrary, fluid loss in patients developing ARF is relatively fast and is the result of excessive sweating or hemorrhage. Since it is known that the hydration state of the body during rhabdomyolysis considerably affects the development of ARF, it seems that the popular model of glycerol injection following a prolonged period of water deprivation in experimental animals is, to a certain extent, deficient. The aim of the present study was to examine two models of ARF formation in the rat following glycerol injection and acute diminution of the body's water content: 1) by sucrose injection (200 mg/100 g), 2) by hemorrhage (0.7 ml/100 g). A number of differences were found between the various models of ARF formation by glycerol. The differences are mainly expressed in the urine volume three hours after the glycerol injection. In the sucrose and hemorrhage groups a decrease of 29% and 66% (p < 0.001) in urine volume was found at the end of the experiment. In contradistinction, in the group that underwent water deprivation for a period of 24 hours prior to the glycerol injection, an increase of 46% (p < 0.001) in the urine volume was observed at the end of the experiment. Differences were also found in potassium uptake and in the extent of the decrease in renal cortex blood flow as measured by the laser Doppler flowmetry technique. From this study it may be concluded that glycerol injection to the rat leg muscle results in ARF in all three methods of decreasing the body's fluid content. It is possible that the models of sucrose injection or hemorrhage prior to glycerol injection are better suited for reflecting the hydration condition of humans suffering from rhabdomyolysis than 24 hours of water deprivation prior to this injection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8679517     DOI: 10.1515/jbcpp.1993.4.3.213

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  6 in total

1.  Immature Dental Pulp Stem Cells Showed Renotropic and Pericyte-Like Properties in Acute Renal Failure in Rats.

Authors:  Michele A Barros; João Flávio Panattoni Martins; Durvanei Augusto Maria; Crisitiane Valverde Wenceslau; Dener Madeiro De Souza; Alexandre Kerkis; Niels Olsen S Câmara; Julio Cesar C Balieiro; Irina Kerkis
Journal:  Cell Med       Date:  2014-03-24

2.  Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in rats.

Authors:  Amrit Pal Singh; Amteshwar Jaggi Singh; Nirmal Singh
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

3.  Nephroprotective effect of ethanolic extract of Azima tetracantha root in glycerol induced acute renal failure in Wistar albino rats.

Authors:  Venugopala Rao Konda; Ruckmani Arunachalam; Madhavi Eerike; Ramesh Rao K; Arun Kumar Radhakrishnan; Lakshmipathy Prabhu Raghuraman; Vinayak Meti; Sobita Devi
Journal:  J Tradit Complement Med       Date:  2015-06-26

Review 4.  Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models.

Authors:  Norbert Kiss; Péter Hamar
Journal:  Biomed Res Int       Date:  2016-11-16       Impact factor: 3.411

Review 5.  Guidelines on processing and clinical use of skin allografts.

Authors:  John N Kearney
Journal:  Clin Dermatol       Date:  2005 Jul-Aug       Impact factor: 3.541

6.  The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy.

Authors:  Shu-Zhi Wang; He He; Rong Han; Jia-Li Zhu; Jian-Qun Kou; Xiao-Lan Ding; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.